Danaher Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Welcome, everybody. My name is Matt Sykes. I'm the senior life science tools and diagnostics analyst at Goldman Sachs. Today, we have the pleasure of having Matt McGrew, the Executive Vice President and Chief Financial Officer; and Matt Gugino, the Head of Investor Relations from Danaher. I guess you have to be named Matt to be part of this panel. So I'm glad we all made it in.
Questions & Answers
But maybe Matt McGrew, I will start with you and just kind of maybe let you set the stage, talk a little bit about the recent quarter, some of the key drivers you see over the course of this year and kind of your views today.
Sure. So I mean I think maybe just kind of revisiting Q1 just to get people sort of grounded a little bit. We had a pretty good start to the year here in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |